Search…
TOP News
Latest
Recommend
HK Stock
US Stock
China Stock
Macro
Bond
Commercial
Global
Investment&Financing
Company&Products
Character
ESG
Economy&politics
Hong Kong
China
America
Stocks
HK Stock
China Stock
US Stock
Markets
HK Stock
US Stock
IPO
Hong Kong
America
China
Research
US Stock
HK Stock
Opinion
Recommendation
TOP News
Latest
Recommend
HK Stock
US Stock
China Stock
Macro
Bond
Commercial
Global
Investment&Financing
Company&Products
Character
ESG
Economy&politics
Hong Kong
China
America
Stocks
HK Stock
China Stock
US Stock
Markets
HK Stock
US Stock
IPO
Hong Kong
America
China
Research
US Stock
HK Stock
Opinion
Recommendation
Search...
TOP News
Latest
Recommend
HK Stock
US Stock
China Stock
Macro
Bond
Commercial
Global
Investment&Financing
Company&Products
Character
ESG
Economy&politics
Hong Kong
China
America
Stocks
HK Stock
China Stock
US Stock
Markets
HK Stock
US Stock
IPO
Hong Kong
America
China
Research
US Stock
HK Stock
Opinion
Recommendation
Home
>
Latest
Lates News
15/05/2025
South Korea's currency supply growth rate in March was 4.9%, down from the previous value of 5.6%.
Latest
2 m ago
Jia Huang Bank: IBM's target price has been raised from $276 to $285.
2 m ago
Jiahuang Bank: IBM's target price has been raised from $276 to $285.
2 m ago
Caidao Securities: Appoints Hu Hengsong as Executive Vice President
4 m ago
German pharmaceutical company Merck announced that adjusted EBITDA for the first quarter increased by 5.6% to 1.54 billion euros, slightly higher than analysts' expectations of 1.51 billion euros. The company lowered its financial guidance, now expecting full-year adjusted EBITDA to be between 5.8 billion and 6.4 billion euros, lower than last year's 6.07 billion euros, to reflect the weakening US dollar and uncertainty surrounding tariff policies.
4 m ago
Due to the weakening of the US dollar and uncertainty in tariff policies, Merck has revised its full-year adjusted earnings forecast.
See all latest